Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MAPK14 Antikörper (AA 19-279)

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch MAPK14 in WB, IHC, IP und ICC. Er zeigt eine Reaktivität gegenüber Ratte.
Produktnummer ABIN7440539

Kurzübersicht für MAPK14 Antikörper (AA 19-279) (ABIN7440539)

Target

Alle MAPK14 Antikörper anzeigen
MAPK14 (Mitogen-Activated Protein Kinase 14 (MAPK14))

Reaktivität

  • 258
  • 164
  • 153
  • 28
  • 25
  • 25
  • 16
  • 14
  • 13
  • 13
  • 9
  • 7
  • 6
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Ratte

Wirt

  • 207
  • 54
  • 2
  • 2
Kaninchen

Klonalität

  • 190
  • 77
Polyklonal

Konjugat

  • 154
  • 11
  • 10
  • 8
  • 7
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser MAPK14 Antikörper ist unkonjugiert

Applikation

  • 200
  • 96
  • 92
  • 58
  • 44
  • 43
  • 42
  • 29
  • 28
  • 23
  • 10
  • 10
  • 9
  • 7
  • 5
  • 5
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
  • Bindungsspezifität

    • 50
    • 34
    • 18
    • 16
    • 15
    • 7
    • 7
    • 7
    • 5
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 19-279

    Verwendungszweck

    Polyclonal Antibody to Mitogen Activated Protein Kinase 14 (MAPK14)

    Spezifität

    The antibody is a rabbit polyclonal antibody raised against MAPK14. It has been selected for its ability to recognize MAPK14 in immunohistochemical staining and western blotting.

    Aufreinigung

    Antigen-specific affinity chromatography followed by Protein A affinity chromatography

    Immunogen

    Recombinant Mitogen Activated Protein Kinase 14 (MAPK14) corresdonding to Glu19~Pro279 with N-terminal His Tag

    Isotyp

    IgG
  • Applikationshinweise

    Western blotting: 0.5-2 μg/mL,Immunohistochemistry: 5-20 μg/mL,Immunocytochemistry: 5-20 μg/mL,Optimal working dilutions must be determined by end user.

    Kommentare

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    500 μg/mL

    Buffer

    PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

    Haltbarkeit

    24 months
  • Target

    MAPK14 (Mitogen-Activated Protein Kinase 14 (MAPK14))

    Andere Bezeichnung

    MAPK14

    Hintergrund

    CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, P38, Mitogen-activated protein kinase p38 alpha, Cytokine suppressive anti-inflammatory drug-binding protein

    Pathways

    MAPK Signalweg, Neurotrophin Signalübertragung, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Regulation of Muscle Cell Differentiation, Regulation of Cell Size, Hepatitis C, Toll-Like Receptors Cascades, Autophagie, Thromboxane A2 Receptor Signaling, BCR Signaling, S100 Proteine
Sie sind hier:
Chat with us!